Head-to-head · free
SL Science vs Soluna
SLBT vs SLNH — return on capital, cash generation, margins and balance sheet side by side.
SLBT
2 / 3
measures where SLBT leads
SLNH
1 / 3
measures where SLNH leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | SLBT | SLNH · FY2025 |
|---|---|---|
| Revenue | — | $29.7M |
| Net income | — | (53.4M) |
| Revenue growth (yearly, multi-year) | — | 20.0% |
| Free cash flow | — | (37.2M) |
| Free cash flow margin | — | -125.2% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | -95.4% | — |
| Gross margin | 35.3% | 21.7% |
| Operating margin | -174.6% | -113.3% |
| Net debt / EBITDA | 0.34x | 2.90x |
Figures are as reported by each company; latest fiscal year shown.
Where Soluna's cash went (FY2025)
- Capital spending
- $28.1M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free